Literature DB >> 10922255

Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors.

A Foroutani1, A M Garland, E Berber, A String, K Engle, T L Ryan, J M Pearl, A E Siperstein.   

Abstract

BACKGROUND: Accurate staging of malignant tumors in the liver has major implications in defining prognosis and guiding both surgical and nonsurgical therapy. Intraoperative ultrasound in open surgery compares favorably with computed tomography (CT) in the detection of liver tumors; however, there is little experience with laparoscopic ultrasound (LUS). HYPOTHESIS: Laparoscopic ultrasound is more sensitive than triphasic CT for detecting primary and metastatic liver tumors.
DESIGN: Prospective study.
SETTING: University hospital. PATIENTS: Fifty-five patients with a total of 222 lesions, including primary and metastatic liver tumors, who underwent both CT examinations and LUS as a part of a tumor ablation procedure.
INTERVENTIONS: Triphasic spiral CT scans of the liver were obtained within 1 week before surgery. Liver LUS was performed with a linear 7.5-MHz side-viewing laparoscopic transducer.
RESULTS: The LUS detected all 201 tumors seen on preoperative CT and detected 21 additional tumors (9.5%) in 11 patients (20.0%). These tumors missed by CT ranged in size from 0.3 to 2.7 cm. Smaller tumors tended to be missed by CT scan (28.6% of the lesions <1 cm, 15.8% of those 1-2 cm, 4% of those 2-3 cm, and 0% of those >3 cm), as did those in segments III and IV. There was good correlation between the size of lesions imaged by the 2 modalities (Pearson r = 0.86; P<.001).
CONCLUSION: Laparoscopic ultrasound offers increased sensitivity over CT for the detection of liver tumors, especially for smaller lesions. This study documents the ability of LUS in detecting liver tumors and argues for more widespread use in laparoscopic staging procedures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922255     DOI: 10.1001/archsurg.135.8.933

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  24 in total

Review 1.  Diagnostic laparoscopy: indications and benefits.

Authors:  Beate Rau; Michael Hünerbein
Journal:  Langenbecks Arch Surg       Date:  2004-05-20       Impact factor: 3.445

2.  Laparoscopic staging for hepatobiliary carcinoma.

Authors:  Rebekah R White; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

3.  The role of echo-laparoscopy in abdominal surgery: five years' experience in a dedicated center.

Authors:  Domenico Piccolboni; Francesco Ciccone; Anna Settembre; Francesco Corcione
Journal:  Surg Endosc       Date:  2007-04-20       Impact factor: 4.584

Review 4.  [Staging laparoscopy in oncology].

Authors:  H Feussner; F Härtl
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

5.  Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience.

Authors:  Koray Karabulut; Federico Aucejo; Hizir Yakup Akyildiz; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2011-10-25       Impact factor: 4.584

6.  Laparoscopic hepatic resection using saline-enhanced electrocautery permits short hospital stays.

Authors:  Peter A Learn; Steven P Bowers; Kevin T Watkins
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

7.  Minimally Invasive Liver Surgery for Hepatic Colorectal Metastases.

Authors:  Ibrahim Nassour; Patricio M Polanco
Journal:  Curr Colorectal Cancer Rep       Date:  2016-03-08

8.  Laparoscopic colectomy for colon cancer: comparable to conventional oncologic surgery?

Authors:  Ricardo M Bonnor; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2005-08

Review 9.  The role of staging laparoscopy for intraabdominal cancers: an evidence-based review.

Authors:  L Chang; D Stefanidis; W S Richardson; D B Earle; R D Fanelli
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

10.  Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases.

Authors:  Robert M Eisele; Ulf Neumann; Peter Neuhaus; Guido Schumacher
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.